Frank J. Formica Sells 5,000 Shares of Petmed Express Inc (PETS) Stock

Petmed Express Inc (NASDAQ:PETS) Director Frank J. Formica sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, June 12th. The stock was sold at an average price of $41.78, for a total value of $208,900.00. Following the sale, the director now owns 48,500 shares of the company’s stock, valued at approximately $2,026,330. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Shares of PETS stock traded down $0.34 during trading on Thursday, hitting $42.61. The company had a trading volume of 26,191 shares, compared to its average volume of 622,053. The stock has a market cap of $851.22 million, a P/E ratio of 23.60, a price-to-earnings-growth ratio of 1.81 and a beta of 1.03. Petmed Express Inc has a one year low of $31.81 and a one year high of $57.80.

Petmed Express (NASDAQ:PETS) last issued its quarterly earnings results on Monday, May 7th. The company reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.03. The business had revenue of $67.30 million during the quarter, compared to analysts’ expectations of $68.43 million. Petmed Express had a return on equity of 34.76% and a net margin of 13.62%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.37 earnings per share. equities research analysts predict that Petmed Express Inc will post 2.28 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, May 25th. Investors of record on Friday, May 18th were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 2.35%. The ex-dividend date of this dividend was Thursday, May 17th. Petmed Express’s dividend payout ratio (DPR) is currently 54.95%.

Several hedge funds have recently modified their holdings of the stock. Redwood Investments LLC bought a new stake in shares of Petmed Express in the first quarter valued at approximately $13,425,000. Elkfork Partners LLC acquired a new position in Petmed Express during the fourth quarter valued at approximately $100,000. MetLife Investment Advisors LLC acquired a new position in Petmed Express during the fourth quarter valued at approximately $429,000. BB&T Securities LLC acquired a new position in Petmed Express during the fourth quarter valued at approximately $254,000. Finally, Municipal Employees Retirement System of Michigan raised its position in Petmed Express by 23.5% during the fourth quarter. Municipal Employees Retirement System of Michigan now owns 20,790 shares of the company’s stock valued at $945,000 after purchasing an additional 3,960 shares in the last quarter. Institutional investors and hedge funds own 96.97% of the company’s stock.

PETS has been the subject of a number of research analyst reports. ValuEngine cut Petmed Express from a “buy” rating to a “hold” rating in a report on Friday, February 23rd. BidaskClub cut Petmed Express from a “hold” rating to a “sell” rating in a research note on Tuesday, April 24th. Craig Hallum cut their price target on Petmed Express to $38.00 and set a “hold” rating for the company in a research note on Tuesday, May 8th. Finally, Zacks Investment Research cut Petmed Express from a “buy” rating to a “hold” rating in a research note on Tuesday, May 8th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $40.00.

Petmed Express Company Profile

PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats to retail customers. It provides non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, thyroid, diabetes, pain medications, antibiotics, and other specialty medications, as well as generic substitutes.

Insider Buying and Selling by Quarter for Petmed Express (NASDAQ:PETS)

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit